Andrea B. Troxel

36.8k total citations · 13 hit papers
357 papers, 23.7k citations indexed

About

Andrea B. Troxel is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Andrea B. Troxel has authored 357 papers receiving a total of 23.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Oncology, 51 papers in Economics and Econometrics and 43 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Andrea B. Troxel's work include Health Systems, Economic Evaluations, Quality of Life (38 papers), Psoriasis: Treatment and Pathogenesis (29 papers) and Cancer survivorship and care (24 papers). Andrea B. Troxel is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (38 papers), Psoriasis: Treatment and Pathogenesis (29 papers) and Cancer survivorship and care (24 papers). Andrea B. Troxel collaborates with scholars based in United States, Canada and United Kingdom. Andrea B. Troxel's co-authors include Joel M. Gelfand, Daniel B. Shin, David J. Margolis, Andrea L. Neimann, Xingmei Wang, Kevin G. Volpp, George Loewenstein, Laurie Norton, Rahat S. Azfar and Kathryn H. Schmitz and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Andrea B. Troxel

349 papers receiving 23.0k citations

Hit Papers

Promotion of tumorigenesi... 2003 2026 2010 2018 2003 2006 2006 2020 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
    2003 1.8k citations Andrea B. Troxel et al. Journal of Clinical Investigation profile →
  2. Risk of Myocardial Infarction in Patients With Psoriasis
    2006 1.4k citations Joel M. Gelfand, Andrea L. Neimann et al. profile →
  3. Prevalence of cardiovascular risk factors in patients with psoriasis
    2006 814 citations Andrea L. Neimann, Andrea B. Troxel et al. profile →
  4. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
    2020 744 citations Samrachana Adhikari, Andrea B. Troxel et al. profile →
  5. Financial Incentive–Based Approaches for Weight Loss
    2008 678 citations Kevin G. Volpp, Leslie K. John et al. profile →
  6. A Randomized, Controlled Trial of Financial Incentives for Smoking Cessation
    2009 602 citations Kevin G. Volpp, Andrea B. Troxel et al. profile →
  7. Phase II Trial of Sorafenib in Advanced Thyroid Cancer
    2008 535 citations Vandana G. Abramson, Andrea B. Troxel et al. Journal of Clinical Oncology profile →
  8. The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis
    2010 522 citations Andrea B. Troxel, Joel M. Gelfand et al. profile →
  9. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
    2009 512 citations Andrea L. Neimann, Andrea B. Troxel et al. profile →
  10. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    2014 409 citations Yunyoung C Chang, Andrea B. Troxel et al. Autophagy profile →
  11. Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom
    2011 386 citations Andrea B. Troxel, Stephen E. Kimmel et al. profile →
  12. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
    2014 354 citations Andrea B. Troxel, Joel M. Gelfand et al. profile →
  13. Cost of Joint Replacement Using Bundled Payment Models
    2017 250 citations Andrea B. Troxel, Jingsan Zhu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea B. Troxel United States 71 6.9k 4.5k 4.0k 3.6k 3.1k 357 23.7k
Robert S. Stern United States 64 5.5k 0.8× 1.9k 0.4× 3.2k 0.8× 2.0k 0.6× 7.7k 2.5× 226 17.7k
Steven R. Feldman United States 85 16.3k 2.3× 3.4k 0.7× 5.6k 1.4× 2.8k 0.8× 19.6k 6.3× 1.3k 36.3k
Daniel H. Solomon United States 96 4.1k 0.6× 3.6k 0.8× 4.1k 1.0× 4.2k 1.2× 492 0.2× 585 36.0k
April W. Armstrong United States 53 8.6k 1.2× 1.4k 0.3× 1.1k 0.3× 1.2k 0.3× 6.3k 2.0× 493 14.0k
Alexa B. Kimball United States 64 9.2k 1.3× 1.0k 0.2× 2.3k 0.6× 777 0.2× 10.1k 3.2× 364 17.4k
Jesse A. Berlin United States 89 1.3k 0.2× 3.1k 0.7× 4.6k 1.1× 2.3k 0.6× 661 0.2× 291 39.7k
María E. Suarez‐Almazor United States 79 2.5k 0.4× 4.4k 1.0× 1.7k 0.4× 2.0k 0.6× 407 0.1× 404 24.1k
Hans‐Olov Adami Sweden 112 2.3k 0.3× 16.8k 3.7× 7.3k 1.8× 6.9k 1.9× 1.1k 0.3× 663 48.1k
Dallas R. English Australia 91 936 0.1× 5.9k 1.3× 3.8k 1.0× 3.8k 1.1× 2.8k 0.9× 592 29.5k
Kenneth G. Saag United States 86 1.8k 0.3× 5.1k 1.1× 2.7k 0.7× 4.9k 1.4× 425 0.1× 476 26.7k

Countries citing papers authored by Andrea B. Troxel

Since Specialization
Citations

This map shows the geographic impact of Andrea B. Troxel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea B. Troxel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea B. Troxel more than expected).

Fields of papers citing papers by Andrea B. Troxel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea B. Troxel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea B. Troxel. The network helps show where Andrea B. Troxel may publish in the future.

Co-authorship network of co-authors of Andrea B. Troxel

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea B. Troxel. A scholar is included among the top collaborators of Andrea B. Troxel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea B. Troxel. Andrea B. Troxel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurz, Sylvia C., Elçin Zan, Andrea B. Troxel, et al.. (2023). Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma. Clinical Cancer Research. 30(4). 680–686. 23 indexed citations
2.
Haberman, Rebecca H., Alan Chen, Andrea L. Neimann, et al.. (2023). Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center. PubMed. 8(4). 134–140. 2 indexed citations
3.
Norweg, Anna, Yinxiang Wu, Andrea B. Troxel, et al.. (2023). Mind–Body Intervention for Dysfunctional Breathing in Chronic Obstructive Pulmonary Disease: Feasibility Study and Lessons Learned. Journal of Integrative and Complementary Medicine. 29(3). 156–168. 5 indexed citations
4.
Duerr, Ralf, Dacia Dimartino, Christian Marier, et al.. (2021). Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City. Journal of Clinical Investigation. 131(18). 34 indexed citations
5.
Troxel, Andrea B., Scott D. Halpern, Kevin G. Volpp, et al.. (2020). Analysis of multicenter clinical trials with very low event rates. Trials. 21(1). 917–917. 4 indexed citations
6.
Clark, Amy S., Nicholas P. McAndrew, Andrea B. Troxel, et al.. (2019). Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer. Clinical Cancer Research. 25(7). 2072–2079. 35 indexed citations
7.
Kessler, Judd B., Andrea B. Troxel, David A. Asch, et al.. (2018). Partners and Alerts in Medication Adherence: A Randomized Clinical Trial. Journal of General Internal Medicine. 33(9). 1536–1542. 19 indexed citations
8.
Brown, Justin C., Andrew D. Rhim, Sara L. Manning, et al.. (2018). Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer. PLoS ONE. 13(10). e0204875–e0204875. 34 indexed citations
9.
Rook, Alain H., Joel M. Gelfand, Maria Wysocka, et al.. (2015). Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. Blood. 126(12). 1452–1461. 164 indexed citations
10.
Rangwala, Reshma, Robert D. Leone, Yunyoung C Chang, et al.. (2014). Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy. 10(8). 1369–1379. 294 indexed citations
11.
Beatty, Gregory L., Drew A. Torigian, E. Gabriela Chiorean, et al.. (2013). A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 19(22). 6286–6295. 364 indexed citations
12.
Kimmel, Stephen E., Andrea B. Troxel, George Loewenstein, et al.. (2012). Randomized trial of lottery-based incentives to improve warfarin adherence. American Heart Journal. 164(2). 268–274. 86 indexed citations
13.
McDonald, Jasmine A., Benita Weathers, Frances K. Barg, et al.. (2012). Donation Intentions for Cancer Genetics Research Among African Americans. Genetic Testing and Molecular Biomarkers. 16(4). 252–258. 14 indexed citations
14.
John, Leslie K., George Loewenstein, Andrea B. Troxel, et al.. (2011). Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial. Journal of General Internal Medicine. 26(6). 621–626. 259 indexed citations
15.
Volpp, Kevin G., Leslie K. John, George Loewenstein, Andrea B. Troxel, & Laurie Norton. (2010). Financial Incentives for Longer-Term Weight Loss: A Randomized Controlled Trial. SSRN Electronic Journal. 1 indexed citations
16.
Elliott, Daniel, Theoklis E. Zaoutis, Andrea B. Troxel, Andrew Loh, & Ron Keren. (2009). Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus. PEDIATRICS. 123(6). e959–e966. 57 indexed citations
17.
Rebbeck, Timothy R., Angela DeMichele, Thanh V. Tran, et al.. (2008). Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis. 30(2). 269–274. 73 indexed citations
18.
Abramson, Vandana G., Andrea B. Troxel, Anoma Nellore, et al.. (2008). Phase II Trial of Sorafenib in Advanced Thyroid Cancer. Journal of Clinical Oncology. 26(29). 4714–4719. 535 indexed citations breakdown →
19.
El‐Tamer, Mahmoud, Donna Russo, Andrea B. Troxel, et al.. (2004). Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers. Annals of Surgical Oncology. 11(2). 157–164. 47 indexed citations
20.
Ayello, Janet, Robert F. Reiss, Andrea B. Troxel, et al.. (1999). CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer. Journal of Hematotherapy & Stem Cell Research. 8(4). 357–363. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Stern Breakdown of academic impact, for papers by Steven R. Feldman Breakdown of academic impact, for papers by Daniel H. Solomon Breakdown of academic impact, for papers by April W. Armstrong Breakdown of academic impact, for papers by Alexa B. Kimball Breakdown of academic impact, for papers by Jesse A. Berlin Breakdown of academic impact, for papers by María E. Suarez‐Almazor Breakdown of academic impact, for papers by Hans‐Olov Adami Breakdown of academic impact, for papers by Dallas R. English Breakdown of academic impact, for papers by Kenneth G. Saag
Rankless by CCL
2026